Meeting
2023 ASCO Annual Meeting
Colorectal cancer screening with blood-based tests: Estimated impact of a 1-, 2-, or 3-year screening interval compared with annual FIT and triennial mt-sDNA strategies.
Authors
A. Mark Fendrick
University of Michigan, Ann Arbor, MI
A. Mark Fendrick , John B. Kisiel , Derek W. Ebner , A. Burak Ozbay , Vahab Vahdat , Chris Estes , Paul J. Limburg
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Prevention
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 10580)
DOI
10.1200/JCO.2023.41.16_suppl.10580
Abstract #
10580
Poster Bd #
213
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Impact of revising colorectal cancer screening guidelines on health care resources in Canada.
First Author: Brendan Chia
Poster
2023 ASCO Annual Meeting
The impact of extending CRC screening to the older population: Results from CRC-AIM microsimulation model.
First Author: Derek W. Ebner
Poster
2022 ASCO Quality Care Symposium
Harnessing academic-community partnerships to improve colorectal cancer screening rates in medically underserved communities.
First Author: Noelle K. LoConte
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Preferences for colorectal cancer screening of physicians and individuals at average risk in the United States: A discrete choice experiment.
First Author: Sebastian Heidenreich